Tracking 45+ Companies & 125+ Open Roles
The career platform for psychedelic medicine
Company intelligence, jobs, clinical trials, and practitioner resources — everything you need to build a career in the emerging psychedelic industry.
45+
Companies tracked
125+
Open positions
2480
Active clinical trials
17
States with legislation
Robin Carhart-Harris, PhD, MAPsilocybin · Healthy Participants With Lower-than-average Mental Well-beingPhase 2·
Rachel YehudaPsilocybin · Psychological StressPhase 2·
Jason SperryKetamine · Traumatic InjuryPhase 3·
Assistance Publique - Hôpitaux de ParisMorphine · Limb InjuryPhase 3·
Icahn School of Medicine at Mount SinaiIV Ketamine · DepressionPhase 2·
University Hospital, GhentPsilocybin · Treatment Resistant DepressionPhase 2·
Dr. med. Marcus HerdenerKetamine · Alcohol Abuse/DependencePhase 2·
Carolyn Rodriguez3 · Obsessive-Compulsive DisorderPhase 2·
Emory University3 · Post Traumatic Stress DisorderPhase 2·
Christian Hassageresketamine · Out-of-hospital Cardiac Arrest (OHCA)Phase 2·
Robin Carhart-Harris, PhD, MAPsilocybin · Healthy Participants With Lower-than-average Mental Well-beingPhase 2·
Rachel YehudaPsilocybin · Psychological StressPhase 2·
Jason SperryKetamine · Traumatic InjuryPhase 3·
Assistance Publique - Hôpitaux de ParisMorphine · Limb InjuryPhase 3·
Icahn School of Medicine at Mount SinaiIV Ketamine · DepressionPhase 2·
University Hospital, GhentPsilocybin · Treatment Resistant DepressionPhase 2·
Dr. med. Marcus HerdenerKetamine · Alcohol Abuse/DependencePhase 2·
Carolyn Rodriguez3 · Obsessive-Compulsive DisorderPhase 2·
Emory University3 · Post Traumatic Stress DisorderPhase 2·
Christian Hassageresketamine · Out-of-hospital Cardiac Arrest (OHCA)Phase 2·
Companies
The psychedelic medicine ecosystem
Stay ahead of the industry
Get updates on new job listings, clinical trial progress, and regulatory changes across all 50 states.